The Embryonic Angiogenic Factor Del1 Accelerates Tumor Growth by Enhancing Vascular Formation
- 1 July 2002
- journal article
- Published by Elsevier in Microvascular Research
- Vol. 64 (1) , 148-161
- https://doi.org/10.1006/mvre.2002.2414
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular developmentGenes & Development, 1999
- Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrestProceedings of the National Academy of Sciences, 1998
- Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.Journal of Clinical Investigation, 1998
- Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.Journal of Clinical Investigation, 1998
- Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3Cell, 1996
- Definition of Two Angiogenic Pathways by Distinct α v IntegrinsScience, 1995
- An antagonist of integrin αvβ3 prevents maturation of blood vessels during embryonic neovascularizationJournal of Cell Science, 1995
- Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vesselsCell, 1994
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Role of extracellular matrix in the action of basic fibroblast growth factor: Matrix as a source of growth factor for long‐term stimulation of plasminogen activator production and DNA synthesisJournal of Cellular Physiology, 1989